Abstract
Substance abuse, smoking, poor nutrition, and depressed immune function often cooccur in high-risk human populations. Studies of drug-addicted populations in the era of AIDS are beginning to bring increased attention and effort to characterizing nutritional and immune status. Similarly, more attention is being directed at nutritional and immunological status of smokers using new methodologies. However, to date, no clear hypotheses of causal biological links between tobacco smoke components, specific drugs, specific nutritional deficiencies, and specific syndromes of immune dysfunction have been proposed and tested.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Preston A. Cigarette smoking-nutritional implications. Prog Food Nutr Sci 1991; 15: 183–217.
Subar A, Harlan L, Mattson M. Food and nutrient intake differences between smokers and nonsmokers in the U.S. Am J Public Health 1990; 80: 1323–9.
McNair E, Bryson R. Effects of nicotine on weight change and food consumption in rats. Pharmacol Biochem Behav 1983; 18: 341–4.
Jias L, Ellison G. Chronic nicotine induces a specific appetite for sucrose in rats. Pharmacol Biochem Behav 1990; 35: 489–91.
Bridges R, Chow C, Rehm S. Micronutrient status and immune function in smokers. Ann NY Acad Sci 1990; 587: 218–31.
Sidney S, Caan B, Friedman G. Dietary intake of beta-carotene in nonsmokers with and without passive smoking at home. Am J Epidemiol 1989; 129: 1305–9.
Emmons K, Thompson B, Feng Z, Hebert J, Heimendinger J, Linnan L. Dietary intake and exposure to environmental tobacco smoke in a worksite population. Eur J Clin Nutr 1995; 49: 336–45.
Matanoski G, Kanchanaraksa S, Lantry D, Chang Y. Characteristics of nonsmoking women in NHANES I and NHANES I epidemiological follow-up study with exposure to spouses who smoke. Am J Epidem 1995; 142: 149–57.
Santolaria-Fernandez F, Gomez-Sirvent J, Gonzalez-Reimers C, Batista-Lopez J, Jorge-Hernandez J, Rodriguez-Moreno R, et al. Nutritional assessment of drug addicts. Drug Alcohol Depend 1995; 38: 11–8.
Varela P, Marcos A, Santacruz I, Ripoll S, Requejo A. Human immunodeficiency virus infection and nutritional status in female drug addicts undergoing detoxification: anthropometric and immunologic assessments. Am J Clin Nutr 1997b; 66: 504S–8S.
Varela P, Marcos A, Santacruz I, Ripoll S, Requejo A. Effects of human immunodeficiency virus infection and detoxification time on anthropometric measurements and dietary intake of male drug addicts. Am J Clin Nutr 1997; 66: 509S–14S.
Johnson A, Knight E, Edwards C, Oyemade U, Cole O, Westney O, et al. Selected lifestyle practices in urban African American women-relationships to pregnancy outcome, dietary intakes and anthropometric measurements. J Nutr 1994; 124: 963S–72S.
Knight E, Hutchinson J, Edwards C, Spurlock B, Oyemade U, Johnson A, et al. Relationships of serum illicit drug concentrations during pregnancy to maternal nutritional status. J Nutr 1994; 124: 973S–80S.
Lopez M, Huang C, Chen G, Watson R. Splenocyte subsets in normal and protein malnourished mice after long-term exposure to cocaine and morphine. Life Sci 1991; 17: 1253–62.
Watson R. LP-BMS, a murine model of acquired immunodeficiency syndrome: role of cocaine, morphine, alcohol and carotenoids in nutritional immunomodulation. J Nutr 1992; 122: 744–8.
Watson R, Mohs M. Effects of morphine, cocaine, and heroin on nutrition. Prog Clin Biol Res 1989; 325: 413–8.
Watson R, Prabhala R, Darban H, Yahya M, Smith T. Changes in lymphocyte and macrophage subsets due to morphine and ethanol treatment during a retrovirus infection causing murine AIDS. Life Sci 1988; 43:v-xi.
Petro R, Watson R, Feely D, Darban H. Alcohol, cocaine, murine AIDS and resistance to Giardia. In: Watson R, ed, Alcohol, Drugs of Abuse and Immunomodulation, pp. 315–30. Pergamon, New York, 1993.
Vaupel DB, Morton EC. Anorexia and hyperphagia produced by five pharmacologic classes of hallucinogens. Pharmacol Biochem Behav 1982; 17: 539–45.
Nozaki M, Vaupel D, Bright L, Martin W. A pharmacological comparison of 3-methoxy-4,5-methylenedioxyamphetamine and LSD in the dog. Drug Alcohol Depend 1978; 3: 153–63.
Cooper S, Jackson A, Kirkham T, Turkish S. Endorphins, opiates and food intake. In: Rodgers R, Cooper J, eds., Endorphins, Opiates and Behavioral Processes, pp. 143–86. Wiley, Chichester, 1988.
Mattes R, Engleman K, Shaw L, Essohly M. Cannabinoids and appetite stimulation. Pharmacol Biochem Behav 1994; 49: 187–95.
Hall W, Solowij N, Lemon J. Health and psychological consequences of cannabis use. National Drug and Alcohol Research Centre, Canberra, 1997.
Farrow J, Rees J, Worthington-Roberts B. Health, developmental and nutritional status of adolescent alcohol and marijuana abusers. Pediatrics 1987; 79: 218–23.
Shaw W. Long-term treatment of obese Zucker rats with LY255582 and other appetite suppressants. Pharmacol Biochem Behav 1993; 46: 653–9.
Wolgin D. Tolerance to amphetamine anorexia: role of learning versus body weight settling point. Behav Neurosci 1983; 97: 549–62.
Leibowitz S, Shor-Posner G, Maclow C, Grinker J. Amphetamineffects on meal patterns and macronutrient selection. Brain Res Bull 1986; 17: 681–9.
Schwartz D, Hoebel B. Effect of phenylpropanolamine on diet selection in rats. Pharmacol Biochem Behav 1988; 31: 721–3.
Marks-Kaufman R. Increased fat consumption induced by morphine administration in rats. Pharmacol Biochem Behav 1982; 16: 949–55.
Morabia A, Fabre J, Chee E, Zeger S. Diet and opiate addiction: a quantitative assessment of the diet of non-institutionalized opiate addicts. Br J Addict 1989; 84: 173–80.
Yeomans M, Wright P. Lower pleasantness of palatable foods in nalmefene-treated human volunteers. Appetite 1991; 16: 249–59.
Mohs M, Watson R, Leonard-Green T. Nutritional effects of marijuana, heroin, cocaine, and nicotine. J Am Diet Assoc 1990; 90: 1261–7.
Holderness C, Brooks-Gunn J, Warren M. Co-morbidity of eating disorders and substance abuse: review of the literature. Int J Eat Disord 1994; 16: 1–34.
Jonas J, Gold M, Sweeney D, Pottash A. Eating disorders and cocaine abuse: a survey of 259 cocaine abusers. J Clin Psychiat 1987; 48: 47–50.
Carlat D, Camargo C, Herzog D. Eating disorders in males: a report on 135 patients. Am J Psychiat 1997; 154: 1127–32.
Strober M, Freeman R, Bower S, Rigali J. Binge eating in anorexia nervosa predicts later onset of substance use disorder: a ten-year prospective, longitudinal follow-up of 95 adolescents. J Youth Adolesc 1996; 25: 519–32.
Cherubin C, Sapira J. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med 1993; 119: 1017–28.
Fidler H, Dhillon A, Gertner D, Burroughs A. Chronic ecstasy (3,4methylenedioxymethamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitis. J Hepatol 1996; 25: 563–6.
Jankovic B, Horvat J, Djordjijevic D, Ramah A, Fridman V, Spahic O. Brain-associated autoimmune features in heroin addicts: correlation to HIV infection and dementia. Int J Neurosci 1991; 58: 113–26.
Roy S, Loh H. Effects of opioids on the immune system. Neurochem Res 1996; 21: 1375–86.
Hollister L. Marihuana and immunity. J Psychoactive Drugs 1992; 24: 159–64.
Watson R. Drugs of Abuse and Immune Function. CRC, Boca Raton, FL, 1990.
Pezzone M, Rush K, Kusnecov A, Wood P, Rabin B. Cortiscosteroneindependent alteration of lymphocyte mitogenic function by amphetamine. Brain Behav Immun 1992; 6: 293–9.
House R, Thomas P, Bhargava H. Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. Immunopharmacol Immunotoxicol 1994; 16: 1–21.
Shen M, Luo Y, Hagen K, Wu Y, Ou D. Immunomodulating activities of cocaine-evaluation of lymphocyte transformation related to other immune functions. Int J Immunopharmacol 1994; 16: 311–9.
Khansari N, Whitten H, Fundenberg H. Phencyclidine-induced immunodepression. Science 1984; 225: 76–8.
House R, Thomas P, Bhargava H. Selective modulation of immune function resuting from in vitro exposure to methylenedioxymethamphetamine (ecstasy). Toxicology 1995; 96: 59–69.
Agshar K. Role of dietary and environmental factors in drug abuse. Alcohol Drug Res 1987; 1987: 61–83.
Wolinsky T, Carr K, Hiller J, Simon E. Effects of chronic food restriction on mu and kappa opioid binding in rat forebrain: a quantitative autoradiographic study. Brain Res 1996; 706: 333–6.
De Vry J, Donselaar I, Van Ree J. Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol. J Pharmacol Exp Therap 1989; 251: 735–40.
Carroll M, Meisch R. Increased drug-reinforced behavior due to food deprivation. Adv Behav Pharmacol 1984; 4: 47–88.
Carr K. Feeding, drug abuse, and the sensitization of reward by metabolic need. Neurochem Res 1996; 21: 1455–67.
Holladay S, Luster M. Developmental Immunotoxicology. In: Kimmel C, Buelke-Sam J, eds, Developmental Toxicology, 2nd ed, pp. 93–118. Raven, New York, 1994.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Golub, M.S. (2000). Cigarette Smoking, Substance Abuse, Nutritional Status, and Immune Function. In: Gershwin, M.E., German, J.B., Keen, C.L. (eds) Nutrition and Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-709-3_22
Download citation
DOI: https://doi.org/10.1007/978-1-59259-709-3_22
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-148-6
Online ISBN: 978-1-59259-709-3
eBook Packages: Springer Book Archive